Ausgabe 3/2009
Inhalt (12 Artikel)
Clinical Trials Report
ONTARGET: Use of ramipril, telmisartan, or both in patients with high cardiovascular risks
HoWon Lee, Amgad N. Makaryus, Samy I. McFarlane
Current Reports / Diabetes / Invited Commentary
Insulin resistance versus β-cell dysfunction in the pathogenesis of type 2 diabetes
Ele Ferrannini
Impact of surgical and nonsurgical weight loss on diabetes resolution and cardiovascular risk reduction
Katherine E. Nori Janosz, Kerstyn C. Zalesin, Wendy M. Miller, Peter A. McCullough, Barry A. Franklin
Treatment of hypertension in metabolic syndrome: Implications of recent clinical trials
Amgad N. Makaryus, Philippe Akhrass, Samy I. McFarlane
Group visits in the management of diabetes and hypertension: Effect on glycemic and blood pressure control
Lisel M. Loney-Hutchinson, Alfrede D. Provilus, Girardin Jean-Louis, Ferdinand Zizi, Olugbenga Ogedegbe, Samy I. McFarlane
Glycemic control and cardiovascular disease in chronic kidney disease
Suma Dronovalli, Basil O. Burney, George L. Bakris